文献速递泌尿生殖腹部MR

非增强磁共振成像用于膀胱癌:高b值扩散加权成像与T2加权成像融合有助于评估浸润深度

Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
PubMed 文献 · Eur Radiol · 2017-02-06

本研究纳入62例经手术证实为膀胱尿路上皮癌的患者,由一名经验丰富的泌尿生殖放射科医生分析T2WI、DWI、T2WI联合DWI及融合MRI评估浸润深度(T分期<2或≥2)。融合MRI的敏感度80.8%、特异度77.8%、准确率79.0%,AUC 0.793,作者认为融合高b值DWI与T2WI可能是一种有前景的非增强MRI技术。

要点

  • 融合MRI评估膀胱癌T分期≥2的AUC为0.793、准确率79.0%。
  • 融合MRI敏感度80.8%、特异度77.8%、PPV 72.4%、NPV 84.9%。
  • 融合MRI诊断性能与T2WI联合DWI相当,作者认为其作为非增强技术有用。

核心结论

  • 融合高b值DWI与T2WI可能是一种有前景的非增强MRI技术,用于评估膀胱癌的浸润深度。

研究设计与样本

  • 纳入62例有MRI检查且经手术证实为膀胱尿路上皮癌的患者,由一名经验丰富的泌尿生殖放射科医生分析T2WI、DWI、T2WI联合DWI及融合DWI与T2WI,以手术证实的T分期(<2或≥2)为参考。

诊断标准与关键数值

  • 手术证实T分期≥2的患者比例为41.9%(26/62)。
  • T2WI评估T分期≥2的敏感度50.0%、特异度55.6%、PPV 44.8%、NPV 60.6%、准确率53.2%,AUC 0.528。
  • DWI评估T分期≥2的敏感度57.7%、特异度77.8%、PPV 65.2%、NPV 71.8%、准确率69.4%,AUC 0.677。
  • T2WI联合DWI评估T分期≥2的敏感度65.4%、特异度80.6%、PPV 70.8%、NPV 76.3%、准确率74.2%,AUC 0.730。
  • 融合MRI评估T分期≥2的敏感度80.8%、特异度77.8%、PPV 72.4%、NPV 84.9%、准确率79.0%,AUC 0.793。

临床应用与阅片要点

  • 融合高b值DWI与T2WI可作为非增强MRI技术用于评估膀胱癌浸润深度,作者认为其有用。
  • 融合MRI诊断性能与T2WI联合DWI相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTS: To investigate the utility of fused high b value diffusion-weighted imaging (DWI) and T2-weighted imaging (T2WI) for evaluating depth of invasion in bladder cancer.

METHODS: We included 62 patients with magnetic resonance imaging (MRI) and surgically confirmed urothelial carcinoma in the urinary bladder. An experienced genitourinary radiologist analysed the depth of invasion (T stage <2 or ≥2) using T2WI, DWI, T2WI plus DWI, and fused DWI and T2WI (fusion MRI). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were investigated. Area under the curve (AUC) was analysed to identify T stage ≥2.

RESULTS: The rate of patients with surgically confirmed T stage ≥2 was 41.9% (26/62). Sensitivity, specificity, PPV, NPV and accuracy were 50.0%, 55.6%, 44.8%, 60.6% and 53.2%, respectively, with T2WI; 57.7%, 77.8%, 65.2%, 71.8% and 69.4%, respectively, with DWI; 65.4%, 80.6%, 70.8%, 76.3% and 74.2%, respectively, with T2WI plus DWI and 80.8%, 77.8%, 72.4%, 84.9% and 79.0%, respectively, with fusion MRI. AUC was 0.528 with T2WI, 0.677 with DWI, 0.730 with T2WI plus DWI and 0.793 with fusion MRI for T stage ≥2.

CONCLUSION: Fused high b value DWI and T2WI may be a promising non-contrast MRI technique for assessing depth of invasion in bladder cancer.

KEY POINTS: • Accuracy of fusion MRI was 79.0% for T stage ≥2 in bladder cancer. • AUC of fusion MRI was 0.793 for T stage ≥2 in bladder cancer. • Diagnostic performance of fusion MRI was comparable with T2WI plus DWI. • As a non-contrast MRI technique, fusion MRI is useful for bladder cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee M, Shin SJ, Oh YT, et al. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur Radiol. 2017. PMID: 28168374. doi:10.1007/s00330-017-4759-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。